Blog - Page 2847 of 5597

MondayOct 07, 2013 8:28 am

On the Move Systems Corp. (OMVS) Aims to Jump-Start Revenues with New Referral Agreement

Today before the opening bell, On the Move Systems said it is finalizing a business development agreement with the Naples Connection, a Florida-based provider of travel and transportation services. The Naples Connection delivers online deals on flights, cruises, hotels, and travel, making the company a natural partner for OMVS as the company prepares to launch its new online transportation portal. According to today’s press release, the companies have nearly finalized an agreement that would find OMVS referring customers to the Naples Connection through its groundbreaking portal in exchange for a share of travel agent commissions. Once an agreement can be…

MondayOct 07, 2013 8:20 am

First Titan Corp. (FTTN) Provides Information on Lucrative New Acquisition Underway

After months of due diligence, First Titan Corp. is extremely close to acquiring a working interest in an area of immense production potential in Southeast Texas. The targeted acquisition is located in Hardin County, Texas, and includes several wells located on over 4,100 leased acres. It possesses potential production from one zone that could potentially be across several wells and drastically increase production in the short term with relatively minimal capital. The zone, which was penetrated and produced in one identified wellbore was prematurely shut-in due to sand incursion. But given current advances in technology, FTTN believes the productive interval…

FridayOct 04, 2013 5:01 pm

Boston Therapeutics, Inc. (BTHE) is “One to Watch”

Boston Therapeutics is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs. An IP portfolio solidifies the company's position in the pharmaceutical industry. Boston Therapeutics' current product pipeline, PAZ320 and IPOXYNT, is comprised of therapies developed to treat patient populations with Type 2 diabetes. PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes that release glucose from complex carbohydrate in foods during digestion. Boston Therapeutics believes PAZ320 is a safe and effective drug compound for people with…

FridayOct 04, 2013 4:24 pm

CD International Enterprises, Inc. (CDII) is “One to Watch”

CD International Enterprises is a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas, in addition to providing business and financial consulting services. Headquartered in Deerfield Beach, Florida, with corporate offices in Shanghai, CD International Enterprises’ unique infrastructure provides a platform to expand business opportunities globally. Through its wholly owned subsidiary, International Magnesium Group, CD International Enterprises owns and operates one of the leading producers of magnesium in the world. International Magnesium Group sources its magnesium from six production facilities in the People's Republic of China, with a combined annual production and distribution capacity…

FridayOct 04, 2013 12:46 pm

StreamTrack, Inc. (STTK) – Changing the Face, and Steep Costs of Online Advertising

To put it into the shallowest of layman’s terms, digital advertising can cost “out the wazoo.” According to Digiday, a media industry company focused on digital media, marketing, and advertising, online advertising generally ranges from $30 CPM (for Hulu in-stream ads) to a whopping $600,000 for a day-long homepage takeover at Yahoo. While no one WANTS to dish out half a million dollars on advertising, the majority of businesses just flat-out can’t afford it. Small-cap technology company StreamTrack believes that effective advertising doesn’t have to break the bank. The company has several means for publishers/broadcasters and advertisers to effectively get…

FridayOct 04, 2013 11:59 am

MetaStat, Inc. (MTST) MetaSite Breast Test Shown to Predict Metastasis in Breast Cancer Study

Systemic metastasis-focused life science company MetaStat announced that a study of nearly 500 female breast cancer patients has demonstrated the value of the company’s MetaSite Breast test in predicting metastatic disease. Albert Einstein College of Medicine of Yeshiva University and Weill Cornell Medical College collaborated on the sponsored study. MetaStat’s MetaSite Breast test is a mechanism-based assay that identifies the tumor microenvironment of metastasis (TMEM) and predicts the likelihood of whether a woman with breast cancer will develop a distant metastasis, including spread to the liver, lungs, bone, brain, and other organs. The assay identifies the microanatomic landmark where tumor…

FridayOct 04, 2013 9:02 am

Nutranomics, Inc. (NNRX) Develops New Line of Cognitive Function Products, Receives First Purchase Order

Nutranomics, a developer of nutritional food products and formulas, reports that online dietary supplement sales company Health Supplement Wholesalers LLC has placed an initial purchase order for a new line of Nutranomics’ nootropic products. Nootropic products are believed to improve brain function, sharpen mental focus, and may have the capability to defer or even reverse the onset of Alzheimer's disease and dementia symptoms. With a specific focus on mental clarity and memory function aspect, Nutranomics has developed a new product line of nootropics for college students. Health Supplement Wholesalers plans to market the new Nutranomics’ product line via its website.…

FridayOct 04, 2013 8:29 am

International Stem Cell Corp. (ISCO) Pioneers Non-Controversial Stem Cell Technology

Biotechnology company International Stem Cell Corp. is focused on using parthenogenesis, its powerful stem cell technology, to treat diseases of the eye, nervous system, and liver – diseases for which cell therapy has been clinically proven but is hampered by the lack of safe immune-matched human cells or tissue. Parthenogenesis uses unfertilized human eggs (oocytes) to create parthenogenetic stem cells (hpSC) that can be immune-matched to millions of people. From a relatively small number of hpSC lines, sufficient immune-matched cells could be provided to accommodate a large portion of the human population. Using unfertilized oocytes offers an ethical advantage over…

ThursdayOct 03, 2013 3:58 pm

New Colombia Resources, Inc. (NEWC) Purchases Greenfield in Colombia Where Their Metallurgical Coal Concession is Located

New Colombia Resources announces they have entered into an agreement to purchase a 50% interest in the San Jose and Santa Isabella farms in Guaduas, Colombia. The company will purchase the remaining interest once they determine it is necessary for their metallurgical coal project. The company will work with the seller to develop sustainable resources on the farms as they develop their underground coal operations. New Colombia's main purpose for purchasing these farms is to have full control of their coal operation without the need to pay royalties to farm owners. The farmland in the area has been increasing in value…

ThursdayOct 03, 2013 3:54 pm

Neutra Corp. (NTRR) Continues to Meet Swelling Horticultural Demand by Developing New Technologies

Neutra, a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, continues to successfully deliver new technology innovations in an effort to meet the swelling demand for life-sustaining fruits, vegetables, and flowers. Significant demand growth in the U.S. horticultural crop market is evidenced by sales projections approaching $71 billion over the next ten years. Neutra’s new joint venture with horticultural innovators Surface to Air Solutions, LLC (S202) was started to help market and develop a sophisticated new portfolio of products calibrated to produce larger and more resilient plants. S202 has created advanced scientific systems capable…

Site Search

Company Search